
ICON Public Limited Company ICLR
$ 176.57
-3.31%
Annual report 2024
added 01-10-2026
ICON Public Limited Company Operating Cash Flow 2011-2026 | ICLR
Annual Operating Cash Flow ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.29 B | 1.16 B | 563 M | 829 M | 568 M | 413 M | 269 M | 383 M | 259 M | 279 M | 170 M | 221 M | 113 M | 20.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.29 B | 20.2 M | 467 M |
Quarterly Operating Cash Flow ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 227 M | - | - | - | 112 M | - | - | - | 143 M | - | - | - | 94.6 M | - | - | - | 40.5 M | - | - | - | 159 M | - | - | - | - | - | - | - | 61.1 M | - | - | - | 38.7 M | - | - | - | 69.4 M | - | - | - | 60.6 M | - | - | - | -5.28 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 227 M | -5.28 M | 91 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Anixa Biosciences
ANIX
|
-7.17 M | $ 3.11 | -2.51 % | $ 101 K | ||
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
884 K | $ 22.32 | -3.71 % | $ 99.4 M | ||
|
BioNano Genomics
BNGO
|
-68.9 M | $ 1.45 | -3.67 % | $ 1.84 M | ||
|
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
-478 M | $ 30.5 | -4.72 % | $ 328 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | ||
|
Castle Biosciences
CSTL
|
64.9 M | $ 40.78 | 1.92 % | $ 1.13 B | ||
|
Co-Diagnostics
CODX
|
-22.1 M | - | - | $ 79.8 M | ||
|
DexCom
DXCM
|
748 M | $ 70.44 | 1.29 % | $ 27.2 B | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Guardant Health
GH
|
-240 M | $ 113.62 | 1.32 % | $ 13.9 B | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
Illumina
ILMN
|
837 M | $ 147.36 | 4.03 % | $ 23.4 B | ||
|
CareDx, Inc
CDNA
|
-18.4 M | $ 20.08 | 0.35 % | $ 1.08 B | ||
|
Danaher Corporation
DHR
|
6.69 B | $ 234.95 | -0.44 % | $ 172 B | ||
|
Celcuity
CELC
|
-83.5 M | $ 105.63 | -1.25 % | $ 4.17 B | ||
|
DarioHealth Corp.
DRIO
|
-30.4 M | $ 12.48 | 0.28 % | $ 354 M | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
21.1 M | $ 27.65 | -1.53 % | $ 836 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Exact Sciences Corporation
EXAS
|
211 M | $ 102.21 | -0.22 % | $ 18.9 B | ||
|
Lantheus Holdings
LNTH
|
545 M | $ 66.02 | 2.75 % | $ 4.57 B | ||
|
Medpace Holdings
MEDP
|
609 M | $ 602.32 | -1.41 % | $ 18.6 B | ||
|
IQVIA Holdings
IQV
|
2.72 B | $ 234.18 | -1.47 % | $ 42.5 B | ||
|
QIAGEN N.V.
QGEN
|
674 M | - | - | $ 10.6 B | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 9.28 | 0.27 % | $ 2.01 B | ||
|
National Research Corporation
NRC
|
38.1 M | $ 22.06 | -0.72 % | $ 541 M | ||
|
Charles River Laboratories International
CRL
|
735 M | $ 219.04 | -0.3 % | $ 11.3 B | ||
|
OPKO Health
OPK
|
-183 M | $ 1.3 | 1.56 % | $ 902 M | ||
|
Pacific Biosciences of California
PACB
|
-259 M | $ 2.36 | 6.79 % | $ 599 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.33 B | $ 188.87 | -0.33 % | $ 21 B | ||
|
Biodesix
BDSX
|
-48.6 M | $ 8.85 | 12.25 % | $ 1.15 B | ||
|
Mettler-Toledo International
MTD
|
968 M | $ 1 409.56 | -3.5 % | $ 29.9 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.59 B | $ 272.02 | 0.42 % | $ 22.8 B | ||
|
IDEXX Laboratories
IDXX
|
929 M | $ 688.67 | -3.73 % | $ 56.8 B | ||
|
Myriad Genetics
MYGN
|
-8.7 M | $ 5.65 | -4.56 % | $ 512 M | ||
|
ENDRA Life Sciences
NDRA
|
-7.4 M | $ 4.67 | -2.3 % | $ 2.51 M | ||
|
Agilent Technologies
A
|
1.48 B | $ 135.52 | -2.95 % | $ 41.2 B |